PDS Biotechnology Corp (PDSB) reports promising trial results and strategic collaborations, despite financial hurdles and trial amendments.

Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Cancer Phase 2 Results Lead Company to Seek Expedited ...

An e-commerce pioneer run from both Biel in Switzerland and Maidenhead in the UK, this Anglo-Swiss brand has undergone a ...